Searched for
APTUS PHARMA LISTING PRICE
Nominal GDP growth could fuel largecap recovery; pharma, auto ancillaries remain preferred bets: Shreyash DevalkarIndian stock markets are defying foreign investor caution, driven by resilient June-quarter earnings. Companies are navigating geopolitical...- Leapfrog Engineering shares list at 4.3% discount from IPO price on BSE SMELeapfrog Engineering Services experienced a subdued market entry, with its shares listing at a 4.3% discount to the IPO price on the BSE SM...
- Vedanta Power, Oil & Gas shares fall 3%; Vedanta Aluminium, Iron & Steel jump up to 5%. What lies ahead?Vedanta's demerger saw mixed fortunes for its listed entities. While Vedanta Power and Oil & Gas shares dipped, Vedanta Aluminium and Iron ...
- Liotech Industries shares list at 20% discount from IPO price on BSE SME platformThe Rs 36.02-crore IPO received a subdued response from investors, with the issue being subscribed 1.91 times during the three-day bidding ...
- Diksha Polymers shares list at 2% premium to IPO price on BSE SME platformDiksha Polymers debuted on the BSE SME platform at a slight premium, opening at Rs 114.50 against its IPO price of Rs 112. The Rs 17.9-cror...
- Clay Craft India shares to list today. Check GMP ahead of debutThe Rs 110.11-crore NSE SME IPO was subscribed 103.06 times during the three-day bidding period, led by strong demand from non-institutiona...
- Indian pharma firms gear up to supply key cancer drug to USIndian drugmakers are stepping up to help the US combat a critical shortage of ifosfamide injection, a vital chemotherapy drug. Leading com...
- NITI Aayog proposes pharma chapter for future FTAs, urges India to move up value chainNiti Aayog proposes a blueprint for free trade agreements to boost regulatory predictability in India's pharmaceutical sector. The think ta...
- Honasa Consumer to acquire majority stake in Fluence Pharma at Rs 135-crore valuationHonasa Consumer has secured a majority stake in Mumbai's hair therapy brand Fluence Pharma for Rs 135 crore. This move marks the company's ...
- Defence valuations 'obnoxious'; private banks look strong: Sandip Sabharwal's full market playbookInvestor Sandip Sabharwal cautions that while the defence rally is real, many stock prices have outpaced reality. He favors Bharat Electron...
- Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
- India's defence export boom could hit ₹65,000 crore by 2030; pvt sector startups the real play: Sunil SubramaniamIndia's defence exports are poised to surpass government targets, reaching ₹60,000-65,000 crore by 2030, according to market expert Sunil S...
- Central Drugs Laboratories find 46 drug samples not of standard quality for MayHealth officials revealed that in May 2026, 46 drug samples tested by Central Drugs Laboratories and 113 by State Drugs Testing Laboratorie...
- 16 fixed-dose combination drugs banned in India: Check full list hereFixed dose combination banned full list: India has banned 16 fixed-dose combination drugs, including certain antibiotics and antispasmodics...
- Plan in the works to let hospitals import med equipment directlyIndia's drug regulator is proposing to allow hospitals to directly import advanced medical equipment like MRI and CT scanners, bypassing cu...
- NSE IPO: BSE hosts double the listed companies but numbers tell a different storyAs NSE prepares for its massive IPO, its DRHP reveals it significantly outperforms BSE in key trading metrics despite having fewer listed c...
- Susan Electricals shares to list today. Check GMP ahead of debutIf the grey market trend holds through listing, the stock could open with gains in that range, continuing the trend of strong debuts seen a...
- Zydus Lifesciences shares fall 2% as firm acquires US-based Assertio Holdings for $166 millionZydus Lifesciences' shares dipped 2% after completing the $166.4 million acquisition of US-based Assertio Holdings Inc. The deal, finalized...
- Vedanta Iron & Steel shares list at Rs 22 on BSE as mega demerger concludesVedanta Iron & Steel debuted on the BSE at Rs 22 and NSE at Rs 20 on Monday as part of Vedanta's demerger plan. The company, with operation...
- Vedanta Aluminium lists at Rs 527 on BSE after demerger. Is it the group’s new crown jewel?Vedanta Aluminium Metal shares debuted on Monday at Rs 527 on the BSE. The company's market capitalization reached Rs 2.06 lakh crore. Anal...
Load More
